Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

BACKGROUND: Mycoplasma genitalium is an emerging sexually transmitted pathogen associated with increasing antibiotic resistance. The current treatment guidelines recommend moxifloxacin-sequential therapy for macrolide-resistant M genitalium or strains with unknown resistance profiles. However, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Naokatsu, Mizushima, Daisuke, Shimizu, Yosuke, Uemura, Yukari, Takano, Misao, Mitobe, Morika, Kobayashi, Kai, Kubota, Hiroaki, Miyake, Hirofumi, Suzuki, Jun, Sadamasu, Kenji, Nakamoto, Takato, Aoki, Takahiro, Watanabe, Koji, Oka, Shinichi, Gatanaga, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685287/
https://www.ncbi.nlm.nih.gov/pubmed/37962941
http://dx.doi.org/10.2196/52565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685287/
https://www.ncbi.nlm.nih.gov/pubmed/37962941
http://dx.doi.org/10.2196/52565

Ejemplares similares